The Correlation Between the Moment of Bevacizumab theRapy initiatiOn and the Efficacy in patieNt With cOlorectal Cancer Treated With AvaStin Based First Line Regimens (CRONOS 1)
N/A
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Both
Colorectal Cancer
Both
Colorectal Cancer
Trial Information
The Correlation Between the Moment of Bevacizumab theRapy initiatiOn and the Efficacy in patieNt With cOlorectal Cancer Treated With AvaStin Based First Line Regimens (CRONOS 1)
Inclusion Criteria:
- Adult patients, >/= the 18 years of age
- Previously untreated metastatic colorectal cancer
- Scheduled to start 1st line chemotherapeutic treatment
- ECOG performance status 0-1
Exclusion Criteria:
- Any conditions included in contraindication list for Avastin
- Prior chemotherapy for metastatic colorectal cancer
- Adjuvant/neoadjuvant chemotherapy or radio-chemotherapy of non-metastatic colorectal
cancer completed <6 months prior to treatment start
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Correlation of the time from the start of chemotherapy to the start of Avastin treatment with progression-free survival
Outcome Time Frame:
60 months
Safety Issue:
No
Principal Investigator
Clinical Trials
Investigator Role:
Study Director
Investigator Affiliation:
Hoffmann-La Roche
Authority:
Romania: Ministry of Health
Study ID:
ML25178
NCT ID:
NCT01277120
Start Date:
April 2010
Completion Date:
September 2014
Related Keywords:
- Colorectal Cancer
- Colorectal Neoplasms
Name | Location |
|---|
